Characteristics and survival of AIDS patients with hepatitis C: the Brazilian National Cohort of 1995–1996

Marins, José; Barros, Marilisa Berti de Azevedo; Machado, Helymar da Costa; Chen, Sanny; Jamal, Leda Fátima; Hearst, Norman

doi:10.1097/01.aids.0000191487.69414.88

Cited by 23 publications

(26 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…6,8 The needles and syringes were bought the majority of the time (89%). The trash was the location for throwing away used syringes and needles, mentioned by 63%.…”

Section: Discussionmentioning

confidence: 99%

“…2, ** A cohort study conducted among AIDS cases diagnosed from 1995 on, found a prevalence rate of 33% for hepatitis C. 6 Another study among IDUs in Santos found high prevalence rates of hepatitis C among IDUs: 84.8% and 20.9% among non IDUs. This indicates that exposure to blood and sexual relations with IDUs are the main risk factors for HCV transmission among HIV positive patients.…”

Section: Introductionmentioning

confidence: 98%

See 1 more Smart Citation

Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil

et al. 2007

View full text Add to dashboard Cite

OBJECTIVE:To describe the profi le of injecting drug users living with HIV/AIDS and estimate hepatitis B and hepatitis C prevalence rates within this group. METHODS:Cross-sectional study conducted with 205 injecting drug users living with HIV/AIDS receiving attention in three public health clinics in the city of Sao Paulo, in 2003. A non-probabilistic sample of volunteers was selected consecutively on the days respondents appeared for their appointments at the clinics. Personal data and information on sexual behavior, drug use and knowledge of hepatitis was collected through interviews. Tests were conducted to detect infections of the hepatitis B and C viruses. RESULTS:Out of the interviewees, 81% were men and 19% women, with an average age of 39 (SD = 6.1) and six years of formal education (SD = 2.0). There was no difference in marital status between the sexes, of which 48% were single, 42% were married, and 8% were divorced. The average ages for fi rst use of tobacco, alcohol and illegal drugs were 13, 15 and 18, respectively. Hepatitis B and C prevalence were 55% (95% CI: 49;63) and 83%(95% CI: 78;88), respectively. Eighty percent of respondents had not heard of Hepatitis B and C prior to the fi rst time they used injecting drugs. CONCLUSIONS:The high prevalence rates of Hepatitis B and C and low level of knowledge regarding the diseases justify the inclusion of information about hepatitis infections and the hepatitis B vaccines in HIV harm reduction strategies.

show abstract

“…6,8 The needles and syringes were bought the majority of the time (89%). The trash was the location for throwing away used syringes and needles, mentioned by 63%.…”

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 98%

Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil

et al. 2007

View full text Add to dashboard Cite

show abstract

“…In a large retrospective study of 833 AIDS patients, 33% were reportedly seropositive for hepatitis C virus [21]. These patients had a higher mortality although this was thought to be multifactorial.…”

Section: Co-infection With Other Oncogenic Virusesmentioning

confidence: 99%

AIDS related malignancies in Brazil

Sampaio

Brites

Araújo

et al. 2007

Current Opinion in Oncology

View full text Add to dashboard Cite

Purpose of review-There have been relatively few studies of HIV-related malignancies in Brazil. Universal access to antiretroviral drugs in Brazil has changed both the mortality and morbidity rates of AIDS. Nevertheless, there is also extreme poverty in both urban and rural areas and complications of prolonged immune suppression such as mycobacterial and malignant diseases have put a significant strain on the country's healthcare system. This brief review outlines the existing data regarding AIDS related malignancies in the largest Latin American country.Recent findings-Currently, there are almost 600 000 people infected with HIV in Brazil and 170 000 patients are receiving highly active antiretroviral therapy. In the studies done of HIV malignancies in Brazil, it appears that these tumors are histologically similar to those that occur in other equatorial countries and differ somewhat from those seen in Europe and the US. Another unique distinction is the high association with oncogenic herpes viruses.Summary-The existence of federally sponsored highly active antiretroviral therapy, clinicians and healthcare providers experienced in the care of HIV patients and high incidence of malignancies associated with oncogenic viruses make Brazil an important site for clinical and basic research in AIDS and immunodeficiency related malignancies.

show abstract

“…During these years, comprehensive response to HIV took place, and after the introduction of highly active antiretroviral therapy (HAART), hepatitis C has also been understood as a risk factor for mortality among people living with HIV/AIDS (PLWHA). 18,19 Considering the importance of viral hepatitis and the demand of structure for prevention and control of this disease at every level of health care, 20,21 We report 12 years of Brazil's experience in confronting hepatitis C infection and its consequences through a public health approach, with universal access as the baseline.…”

Section: Introductionmentioning

confidence: 99%

12 Years of Universal Access to Hepatitis C Treatment

Naveira¹,

Barbosa

Sereno

et al. 2014

J Int Assoc Provid AIDS Care

View full text Add to dashboard Cite

Hepatitis C is considered one of the most neglected diseases in world. Worldwide about 150 million people are chronically infected by hepatitis C virus (HCV), and 60% to 70% of them will develop severe liver disease. This article describes Brazil's response to hepatitis C, from the first steps in 1993 to a national program in 2002. We reviewed the available literature, most of it in Brazilian Portuguese, and compiled them in order to share this experience with those seeking some pragmatic solutions. After 12 years, the national program has achieved universal coverage of treatment, resulting in saved lives and resources for the health system. There is abundant evidence that the HCV epidemic deserves attention. The overall consequence of long-term HCV infection is a negative impact on the health care economy. The Brazilian experience can be adapted to many countries in the world, in compliance with the 2010 World Health Organization World Health Assembly Resolution.

show abstract

Characteristics and survival of AIDS patients with hepatitis C: the Brazilian National Cohort of 1995–1996

Cited by 23 publications

References 19 publications

Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil

Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil

AIDS related malignancies in Brazil

12 Years of Universal Access to Hepatitis C Treatment

Contact Info

Product

Resources

About